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Herpes zoster ophthalmicus and HIV are serious health problems. We report a case of a 37-year-old
woman who presented to the Korle-Bu Teaching Hospital with dyspnea and facial cellulitis, and a
diagnosis 5 days prior of dental cellulitis made at a district hospital. Investigations revealed that the facial
cellulitis was secondary to herpes zoster infection involving the ophthalmic division of the left trigeminal
nerve. The patient responded well to oral acyclovir but developed postherpetic neuralgia. During the
course of treatment, she was also diagnosed to be HIV-1 positive and was referred for further man-
agement. This case represents a unique report in which the patient presented to the hospital with
symptoms of cellulitis suggestive of underlying dental infection but was later diagnosed with both
herpes zoster ophthalmicus and an underlying HIV infection. Atypical presentations of herpes zoster can
occur in HIV/AIDS. Signs of herpes zoster infection with cellulitis should alert the clinician that the
patient may have a possible underlying immunosuppressive disease. The population must be educated
regarding the importance of early presentation and careful compliance with treatment as well as regular
follow-ups.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Herpes zoster (HZ) is an infection caused by reactivation of the
varicella-zoster virus (VZV), also known as human herpes virus
type 3. Studies in 1958 identiﬁed the virus causing HZ as identical to
that which causes chicken pox [1]. VZV is a member of the family of
herpesviridae, which includes the cytomegalovirus, herpes sim-
plex, and Epstein-Barr viruses. Since the licensing of the varicella
vaccine in the United States in 1995, the incidence of symptomatic
varicella infection in childhood has been reduced by >80% [2,3].
Despite this, there are currently over 1 million cases of VZV in the
United States each year with a lifetime attack rate of 30% [2,3]. The
incidence of VZV increases with age, especially between the ﬁfth
and eight decades of life in the temperate climates of the United
States and the UK [2,4,5]. This trend has also been observed in more
tropical climates such as Thailand [6].xillofacial Surgery, University
, P.O. Box KB 460, Korle-Bu,
4147.
.
Inc. This is an open access article uThe varicella virus remains latent in the dorsal root ganglion of a
nerve after initial infection [3,4]. When the virus is reactivated, it
travels along the sensory nerve axon to cause shingles (HZ) [3].
Symptoms generally manifest along a single dermatome. The
thoracic segments of the trunk are most commonly involved;
however, divisions of the trigeminal nerve are affected in 10%-30%
of cases [7,8]. Herpes zoster ophthalmicus occurs when a latent
varicella-zoster virus in the trigeminal ganglion is reactivated to
involve the ophthalmic division of the trigeminal nerve. The
ophthalmic division is involved 20 times more frequently than the
maxillary or mandibular division of the trigeminal nerve [2,7].
Ocular complications occur in an estimated 25%-30% of patients
with herpes zoster ophthalmicus and include stromal and neuro-
trophic keratitis, anterior uveitis, scleritis, infectious retinitis,
cranial nerve palsies, and postherpetic neuralgia. Corneal compli-
cations have been reported in 65% of patients [7].
HZ occurs more frequently in older individuals [2]. Increased
incidence of zoster is also observed in immunosuppressed pop-
ulations [9], including those receiving systemic steroid therapy,
chemotherapy, and radiation that subsequently decrease the
effectiveness of cytotoxic T cellemediated immunity [2]. Risknder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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recent trauma or psychological stress [2]. HIV-positive patients
have a 15- to 25-fold greater prevalence of varicella zoster
compared with the general population [2,7]. We present a unique
case of herpes zoster ophthalmicus with its management that was
initially suspected to represent a dental cellulitis and referred to the
Korle-Bu Teaching Hospital (KBTH) for further management by the
Oral and Maxillofacial Surgery Clinic.
2. Presentation of case
A 37-year-old woman presented to the district hospital with
progressive left facial swelling of 5 days duration. She reported
working as a trader and being married with 4 children. She denied
any signiﬁcant history of tobacco or alcohol use. There were no
identiﬁed drug allergies or use of medications, including herbal
preparations. Her medical history indicated a rash that was not
present at the time of initial presentation, nor was it well enough
described to provide any substantive information to the differential
diagnosis.
At the district hospital, examination revealed a fully conscious,
breathless, acutely ill-looking female with signiﬁcant pain and
facial swelling extending to the lateral aspect of her left neck. No
vesicles were noted at this time. Ptosis of the left eyelid was pre-
sent. She was mildly pale with no evidence of jaundice, cyanosis, or
clubbing. Her cardiovascular status included a regular pulse rate of
100 bpm and blood pressure of 90/70 mm Hg. Heart sounds were
present with no murmurs, and her chest was clinically clear. Owing
to a suspicion of an underlying dental infection, an initial diagnosis
of dental cellulitis was made. The patient was given the narrow-
spectrum beta-lactam antibiotic ﬂucloxacillin (500 mg 4 times
daily), ibuprofen (400mg 3 times daily), and Funbact-A cream (Bliss
GVS Pharmaceutical Co., Mumbai, India), a topical formulation that
contains (1) a synthetic antifungal, clotrimazole 1.0%, (2) a topical
corticosteroid, betamethasone dipropionate 0.05%, and (3) a broad
spectrum antibiotic, neomycin sulfate 0.5%. She was then referred
to the KBTH for further management by the Oral and Maxillofacial
Surgery clinic.
On presentation to the KBTH, 5 days after presentation at the
district hospital, the patient described a burning sensation and
severe pain on the left side of her face. Vesicles had appeared along
her hairline in the region of distribution of the left ophthalmic di-
vision of the trigeminal nerve, apparently after she had braided her
hair 5 days prior. Rupturing of the vesicles occurred shortly after
initial formation, resulting in crusting. The patient experienced
difﬁculty in breathing, as well as fever and chills. She was unable to
open her eyes bilaterally with increased restriction in the left eye.Figure 1. (A) Initial presentation. (B) One month afterExtraoral examination showed facial cellulitis with severe pain
along with ulceration and crusting affecting the left ophthalmic
division of the trigeminal nerve (Figure 1A). There were also several
vesicles present in the affected area.
Differential diagnosis was highly suggestive of herpes zoster
ophthalmicus, although panfacial cellulitis secondary to use of
herbal preparations, cavernous sinus thrombosis, and dentoalveo-
lar infection were also considered. Management of the patient
included investigations of full blood count, sickling test, blood urea
and electrolytes, creatinine, and Retroscreen for HIV infection. Re-
sults of the laboratory investigations included hemoglobin 11.9 g/dL
(normal, 12-16 g/dL), platelets 225  109/L (normal, 150-400  109/
L), andwhite blood cell count 4.4109/L (normal, 4.3-10.8 109/L).
Retroscreen was positive for HIV-1 infection, and a written referral
was made to the fevers unit for further management.
Oxygen via face mask and intravenous (IV) ﬂuids were admin-
istered. Medications given were as follows: tablet acyclovir 800 mg
5 times daily for 7 days, IV Flagyl (Eskay Therapeutics, Accra, Ghana)
500 mg every 8 hours for 48 hours, IV gentamicin 80 mg every 8
hours for 48 hours, IV dexamethasone 8 mg stat., followed by 4 mg
every 8 hours for 48 hours, suppository diclofenac 100 mg twice
daily for 5 days, vitamin B complex 1 tablet daily for 2 weeks, tablet
Metran (Daewon Pharmaceutical Companies. Ltd, Busan, South
Korea) 1 twice daily for 2 weeks, and Neo Hycolex eye drops
(Tobinco Pharmaceutical Ltd., Accra, Ghana).
The patient gradually improved and continued treatment as an
outpatient under care of an ophthalmologist. One month later, the
patient returned for follow-up from the fevers unit with a CD4
baseline of 183 cells/mL (normal, 500-1200, AIDS <200), com-
plaining of loss of vision in her left eye and persistent pain in the
affected area consistent with the diagnosis of postherpetic neu-
ralgia (Figure 1B). This further conﬁrmed the diagnosis of herpes
zoster ophthalmicus. At that time, she had not yet begun antire-
troviral treatment. The patient was seen 7 months later with
healing but extensive scarring of the forehead, eyelid, and cornea
(Figure 1C) with persistent loss of vision in the eye. She continued
reviewwith the ophthalmologist and was on antiretroviral therapy.
At her follow-up appointment 2 years later, she had complete loss
of vision in the left eye and hopes for corneal implant.
3. Discussion
HZ infection is produced by the reactivation of the latent
varicella-zoster virus from the dorsal root ganglia of sensory nerves.
Major risk factors for HZ include immunosuppression and
decreased cell-mediated immunity. Other risk factors include an
elderly population and those with poor nutrition. For anypresentation. (C) Seven months after treatment.
G.E. Parkins et al. / Oral and Maxillofacial Surgery Cases 1 (2015) 5e7 7population that includes these risk factors, the practitioner should
have a heightened sense of awareness toward the possibility of
herpes zoster ophthalmicus [1,2,7]. Approximately 9% of patients
with HZ, of which there are over 1 million per year in the United
States, have complications involving the eye [2,3,8].
This case represents a unique report in which the patient pre-
sented to the hospital with symptoms of cellulitis suggestive of
underlying dental infection and was referred to an oral and
maxillofacial surgeon for management. After presentation to the
oral surgeon, the patient was diagnosed with both herpes zoster
ophthalmicus and an underlying HIV infection. HIV is a serious
health problem, and HZ can be the initial presentation of the dis-
ease [1,2].
HZ begins with a prodromal stage of ﬂu-like illness with fatigue,
low-grade fever, and chills that last up to 1 week before the char-
acteristic skin lesions appear. Sixty percent of patients complain of
pain [2]. Erythematous macules then appear along the involved
dermatome. Over several days, they progress into papules and
vesicles and later pustules that rupture and crust, taking several
weeks to heal. HIV-positive patientsmay have generalized vesicular
rash and become ill 1-2 weeks after the onset of the disease.
Herpes zoster ophthalmicus can present with extraocular and
ocular manifestations. Infection and inﬂammation secondary to HZ
can affect virtually all adnexal, ocular, and orbital tissues [2,7,9,10].
The skin manifestations of herpes zoster ophthalmicus involve 1
branches of the ophthalmic division of the trigeminal nerve. These
include the supraorbital, supratrochlear, lachrymal, infratrochlear,
and external nasal (a branch of the nasociliary) branches. Because
the nasociliary branch innervates the cornea, the most serious
ocular involvement occurs if this branch is affected. Eyelids are also
commonly affected [2,7]. Patients can develop blepharitis, and this
can lead to secondary bacterial infection, eyelid scarring, marginal
notching, loss of eyelashes, trichiasis, and cicatricial entropion.
Scarring and occlusion of the lachrymal puncta or canaliculi can
occur. Ptosis secondary to edema and inﬂammation may also be
present. Some of these signs were observed in this case with
inﬂammation of the patient’s eyelids and subsequent crusting,
retraction, and deformity of her left eyelid (Figure 1C). Unlike this
case, most patients will have vesicular lesions that resolve with
minimal scarring.
Some of the complications that can appear in the course of
herpes zoster ophthalmicus are corneal neovascularization and
scarring resulting in poor vision. Other complications are neuro-
trophic ulcer with perforation, secondary bacterial or fungal
infection and secondary glaucoma from uveitis and steroid treat-
ment. Necrotizing interstitial keratitis, postherpetic neuralgia, and
loss of vision from optic neuritis or chorioretinitis can also occur
[2,7,9].
Herpes zoster ophthalmicus can be successfully managed with
systemic antivirals (acyclovir 800 mg 5 times per day for 1 week to
10 days) [7], sometimes in combination with tricyclic antidepres-
sants to inhibit the infectious inﬂammatory component of the
associated pain [2]. Antiviral agents may decrease the severity and
duration of the pain if given early in the course of the illness.Antibiotics should also be given if secondary bacterial infection of
the vesicles has occurred. For acute retinal necrosis, the acyclovir
may be administered intravenously (1500 mg/d divided into 3
doses) for 7-10 days with long-term oral acyclovir follow-up (w14
weeks of 800 mg 5 times daily) [7,10]. Unfortunately, oral acyclovir
has little effect on the incidence, severity, or duration of post-
herpetic neuralgia.4. Conclusion
HIV and HZ are serious health problems. The initial presentation
of the disease in this case was mistakenly a dental cellulitis. Com-
plications and atypical presentations of HZ are common in pop-
ulations with a high burden of HIV/AIDS. Recognition of the early
signs of HZ allows for early clinical diagnosis and intervention. In
rural settings where access to health services is difﬁcult, the general
population should be educated regarding the importance of early
presentation and careful compliance with treatment as well as
regular follow-ups.Consent
Written informed consent was obtained from the patient for
publication of this case report and the accompanying image. A copy
of the written consent is available for review by the Editor-in-Chief
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